NEW YORK (GenomeWeb News) – Luminex today announced that it has licensed its xMAP technology and the Luminex Bioscience Group’s assay development capabilities to Wageningen University and Research Center in the Netherlands.

 

Wageningen will use the xMAP multiplex technology for a variety of agricultural biotech areas including plant pathogen detection, epidemiology, food safety, and marker-assisted plant and animal breeding programs. Financial terms of the agreement were not disclosed.